4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0002085679-25-000004
Options or other derivatives
- Chief Business Officer acquired 255,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Beer Caroline Stark Chief Business Officer | 2025-10-01 | Grant or award · Non-Qualified Stock Option (right to buy) | +255,000 | 255,000 | D | ||
Loading xslF345X05/edgardoc.xml…